Xcout IntelSign inSubscribe

Pacira BioSciences, Inc. competitors & alternatives

PCRXPharmaceuticalsBrisbane, United States

The 12 closest competitors and alternatives to Pacira BioSciences, Inc. among pharmaceuticals companies — ranked by similarity to what Pacira BioSciences, Inc. actually does, not by market-cap band.

$1.4BMarket cap
827Employees
12Competitors listed

Subscribe to see Pacira BioSciences, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About Pacira BioSciences, Inc.

Pacira BioSciences, Inc. is a pharmaceutical company headquartered in Brisbane, California, focused on transforming how the world treats pain.

Pacira BioSciences, Inc. at a glance

Pacira BioSciences, Inc. is a pharmaceuticals company headquartered in Brisbane, United States. It is publicly listed (PCRX) with a market capitalisation of $1.4B. Xcout tracks 27 named people at Pacira BioSciences, Inc., including Frank D. Lee (Chief Executive Officer & Director).

Pacira BioSciences, Inc. leadership

  • Frank D. LeeChief Executive Officer & Director
  • Shawn CrossChief Financial Officer
  • Brendan TeehanChief Commercial Officer
  • Jonathan SloninChief Medical Officer
  • Kristen WilliamsChief Administrative Officer & Secretary
  • Anthony MolloyChief Legal & Compliance Officer

21 more named people on record for Pacira BioSciences, Inc., with roles, board committees and tenure — see the full roster →

Recent Pacira BioSciences, Inc. news

Top 12 Pacira BioSciences, Inc. competitors

Ranked by semantic similarity — how close each company is to Pacira BioSciences, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

Bausch Health Companies Inc.BHC · PharmaceuticalsLaval, Canada
62% matchPublic

Similar pharmaceuticals company

Bausch Health Companies Inc., together with its associated entities, is engaged in the development, manufacturing, and commercialization of a diverse portfolio of pharmaceutical products, medical devices, and over-the-counter remedies. Its primary therapeutic focus areas include ophthalmology, digestive health, and dermatology. The enterprise conducts its operations through five principal divisions: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment is dedicated to vision care, encompassing surgical instruments, consumer eye health products, and ophthalmic pharmaceuticals. Salix specializes in delivering gastroenterology-specific products exclusively within the United States. The International Rx division markets Solta products, a range of branded and generic pharmaceuticals, OTC items, medical devices, and Bausch + Lomb offerings across diverse geographies including Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. Ortho Dermatologics focuses on dermatological products in the U.S., in addition to distributing Solta's medical aesthetic devices globally. Finally, the Diversified Products segment supplies pharmaceutical solutions for neurology and other therapeutic categories, as well as generic medications and dental products, all within the U.S. The company was formerly known as Valeant Pharmaceuticals International, Inc., officially changing its name to Bausch Health Companies Inc. in July 2018. Its corporate headquarters are located in Laval, Canada.

Market cap$1.8B
Employees20,300
Bausch Health Companies Inc. competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of Pacira BioSciences, Inc. and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for Pacira BioSciences, Inc.and every competitor above — in one live dashboard.

Subscribe to Xcout Intel →